Vera Therapeutics VERA Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -71.3%-31.8pp | -50.7%-5.9pp | -73.2%-8.1pp | -54.8%-8.8pp | -39.5%-2.6pp | |
| Return on invested capital | -77.1%-32.8pp | -72.8%-21.3pp | -73.5%-7.9pp | -55.4%-7.8pp | -44.3%+8.1pp | |
| Liquidity | ||||||
| Current ratio | 13.6×-14.0× | 13.6×-12.0× | 12.2×-1.6× | 17×-4.4× | 27.7×-0.9× | |
| Leverage | ||||||
| Debt-to-equity | 0.2×0.0× | 0.1×0.0× | 0.2×0.0× | 0.2×0.0× | 0.1×0.0× | |
| Per Share | ||||||
| Book value per share | $6.99-16.8% | $9.41-9.8% | $6.25+18.7% | $7.34+22.5% | $8.40+21.1% | |
| Valuation | ||||||
| Market capitalization | $2.87B+87.5% | $3.59B+34.2% | $1.85B-23.3% | $1.44B-21.9% | $1.53B-20.1% | |
| Price / book | 5.7×+2.9× | 5.9×+1.3× | 4.6×-3.7× | 3.1×-2.5× | 2.9×-2.6× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Vera Therapeutics's ratios come from?
- Every ratio is computed from Vera Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.